Use filters to refine the search results.
Results 1-5 of 5
|31-May-1998||High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factors||Lyttelton, MPA; Newlands, ES; Giles, C; Bower, M; Guimaraes, A, et al|
|11-Apr-1998||Framework for analysing risk and safety in clinical medicine.||Vincent, C; Taylor-Adams, S; Stanhope, N|
|1-Oct-1998||High dose etoposide with granulocyte colony-stimulating factor for mobilization of peripheral blood progenitor cells: efficacy and toxicity at three dose levels||Kanfer, EJ; McGuigan, D; Samson, D; Abboudi, Z; Abrahamson, G, et al|
|1-Jul-1998||A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer||Gulliford, T; English, J; Colston, KW; Menday, P; Moller, S, et al|
|1-Mar-1998||p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation||Honda, K; Sbisa, E; Tullo, A; Papeo, PA; Saccone, C, et al|